Related Experiment Video
Updated: Sep 27, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Antioxidants as a Link Between Diabetes and Potential Plant-Based Therapies
Alina Kuryłowicz1, Leszek Dobrowolski2, Monika Słupecka-Ziemilska1
1Department of Human Epigenetics, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 A. Pawińskiego Street, 02-106 Warsaw, Poland.
Abstract:
The pathogenesis and advancement of diabetes mellitus and its associated complications are heavily driven by oxidative stress (OS). It happens when the body produces excessive amounts of reactive oxygen and nitrogen species (RONS). This causes cell damage and leads to chronic health issues, prompting scientific interest in antioxidant-based treatments. In the context of chronic diseases, such as diabetes, the search for new natural bioactive compounds is of particular importance. Within the realm of traditional healthcare, Ayurveda commands significant scientific interest. Botanical materials in the Ayurvedic tradition frequently demonstrate a wide array of physiological benefits, including (among others) hypoglycaemic and antioxidant effects. Because numerous contemporary medications trace their origins back to natural compounds-with metformin serving as a primary example-investigating these traditional botanicals could be instrumental in identifying novel pharmacological treatments. This review focuses on three traditionally used for diabetes: bitter melon (Momordica charantia), gurmar (Gymnema sylvestre), and jambolan (Syzygium cumini). Their therapeutic properties-such as antioxidant, immuno-modulatory, and anti-inflammatory effects-stem from diverse phytochemicals including alkaloids, flavonoids, polypeptides, polysaccharides, saponins and sterols. Together, their overlapping effects create a powerful, unified approach to managing diabetes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational